|Articles|January 23, 2023

At-line Spent Media Analysis using the REBEL to Optimize a CHO mAb Fed-Batch Process

Author(s)908 Devices

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.